Table 1.
Correlations Between circSOBP Expression and Clinicopathological Characteristics in BCa.
| Parameter | Case | circSOBP expression | P value | |
|---|---|---|---|---|
| Low (28) | High (28) | |||
| Gender | 1.000 | |||
| Female | 7 | 3 (5.4%) | 4 (7.1%) | |
| Male | 49 | 25 (44.6%) | 24 (42.9%) | |
| Age | 0.469 | |||
| <60 | 9 | 3 (5.4%) | 6 (10.7%) | |
| ≥60 | 47 | 25 (44.6%) | 22 (39.3%) | |
| Tumor size | 0.015* | |||
| <3cm | 24 | 7 (12.5%) | 17 (30.4%) | |
| ≥3cm | 32 | 21 (37.5%) | 11 (19.6%) | |
| Pathology stage | 0.007* | |||
| pTa-pT1 | 31 | 10 (17.9%) | 21 (37.5%) | |
| pT2-pT4 | 25 | 18 (32.1%) | 7(12.5%) | |
| Grade, n (%) | 0.491 | |||
| Low | 2 | 2 (3.6%) | 0 (0%) | |
| high | 54 | 26 (46.4%) | 28 (50%) | |
| Lymphatic metastasis status | 0.329 | |||
| N0 | 44 | 24 (42.9%) | 20 (35.7%) | |
| N1 | 12 | 4 (7.1%) | 8 (14.3%) | |
| Distant metastasis status | 1.000 | |||
| M0 | 55 | 28 (50%) | 27 (48.2%) | |
| M1 | 1 | 0 (0%) | 1 (1.8%) | |
BCa: bladder cancer.
*
P < 0.05.